Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Chiappella · SciRah

Researcher profile · Semantic Scholar

A. Chiappella

Share profile

A. Chiappella — researcher profile on SciRah

h-index: 40
Works: 276
Citations: 5,269

Most-cited papers

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma
G. Nowakowski, A. Chiappella, R. Gascoyne, D. Scott +26 more
2021Journal of Clinical Oncology230 citations Open access
Semantic Scholar
ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R2‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma
U. Vitolo, T. Witzig, R. Gascoyne, David W. Scott +24 more
2019Hematological Oncology88 citations
Semantic Scholar
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
G. Iacoboni, K. Rejeski, G. Villacampa, J. V. van Doesum +18 more
2021Blood Advances83 citations Open access
Semantic Scholar
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study
C. Visco, A. Di Rocco, A. Evangelista, F. Quaglia +29 more
2020Leukemia68 citations Open access
Semantic Scholar
Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma
C. Monfrini, F. Stella, V. Aragona, M. Magni +10 more
2022Clinical Cancer Research61 citations Open access
Semantic Scholar
OUTCOMES IN FIRST RELAPSED‐REFRACTORY YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: RESULTS FROM THE MANTLE‐FIRST STUDY
C. Visco, A. Di Rocco, M. Tisi, Lucia Morello +26 more
2019Hematological Oncology49 citations
Semantic Scholar
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project.
A. Shustov, M. Cabrera, M. Civallero, M. Bellei +17 more
2021Blood Advances47 citations Open access
Semantic Scholar
Ibrutinib improves survival compared to chemotherapy in mantle cell lymphoma with central nervous system relapse.
C. Rusconi, Che-Ah Y. Chan, T. Eyre, D. Tucker +28 more
2022Blood40 citations Open access
Semantic Scholar
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome
A. Dodero, A. Guidetti, Fabrizio Marino, A. Tucci +19 more
2021Haematologica40 citations Open access
Semantic Scholar
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B‐cell lymphoma patients treated in the FIL‐DLCL04 trial
A. Chiappella, F. Diop, C. Agostinelli, M. Novo +16 more
2021British Journal of Haematology36 citations Open access
Semantic Scholar
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial.
M. Ladetto, S. Cortelazzo, S. Ferrero, A. Evangelista +25 more
2021The Lancet Haematology35 citations Open access
Semantic Scholar
CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
F. Maura, A. Dodero, C. Carniti, N. Bolli +15 more
2020Haematologica34 citations Open access
Semantic Scholar
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study
A. Chiappella, B. Casadei, P. Chiusolo, A. Di Rocco +28 more
2024Leukemia31 citations Open access
Semantic Scholar
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma
A. Conconi, A. Chiappella, A. Ferreri, A. Stathis +25 more
2024Blood Advances28 citations Open access
Semantic Scholar
Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study.
J. Michot, R. Bouabdallah, U. Vitolo, J. Doorduijn +16 more
2020The Lancet Haematology27 citations Open access
Semantic Scholar
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas
F. Stella, A. Chiappella, B. Casadei, S. Bramanti +26 more
2024Blood Cancer Discovery25 citations Open access
Semantic Scholar
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
A. Chiappella, A. Dodero, A. Evangelista, A. Re +31 more
2023Leukemia25 citations Open access
Semantic Scholar
Outcome after chimeric antigen receptor (CAR) T‐cell therapy failure in large B‐cell lymphomas
A. Dodero, S. Bramanti, M. di Trani, M. Pennisi +13 more
2023British Journal of Haematology23 citations Open access
Semantic Scholar
Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma
G. Nowakowski, A. Chiappella, T. Witzig, D. Scott +8 more
2020Haematologica23 citations Open access
Semantic Scholar
Monocytes in leukapheresis products affect the outcome of CD19–targeted CAR T-cell therapy in patients with lymphoma
C. Carniti, N. Caldarelli, L. Agnelli, Tommaso Torelli +12 more
2024Blood Advances20 citations Open access
Semantic Scholar
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy
M. Marangon, C. Visco, A. Barbui, A. Chiappella +8 more
2021Cancers20 citations Open access
Semantic Scholar
NR1H3 (LXRα) is associated with pro‐inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b‐cell lymphoma
M. C. Vegliante, S. Mazzara, G. Zaccaria, S. De Summa +33 more
2022Hematological Oncology19 citations Open access
Semantic Scholar
INTENSIFIED (INTRAVENOUS AND INTRATHECAL) CNS PROPHYLAXIS IN PRIMARY TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: 5‐YEAR RESULTS OF THE IELSG30 TRIAL
A. Conconi, A. Chiappella, L. Orsucci, G. Gaidano +12 more
2021Hematological Oncology19 citations
Semantic Scholar
Prospective Validation of CAR-HEMATOTOX and a simplified version predict Survival in Patients with Large B-Cell Lymphoma treated with anti-CD19 CAR T-cells: data from CART-SIE study.
F. Stella, M. Pennisi, A. Chiappella, B. Casadei +27 more
2025Transplantation and Cellular Therapy17 citations Open access
Semantic Scholar
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
A. Broccoli, B. Casadei, A. Chiappella, C. Visco +22 more
2019The Oncologist16 citations Open access
Semantic Scholar
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti‐CD19 chimeric antigen receptor T‐cell efficacy
A. Guidetti, A. Dodero, A. Lorenzoni, S. Pizzamiglio +11 more
2022Cancer15 citations Open access
Semantic Scholar
Secondary primary malignancies after CD‐19 directed CAR‐T‐cell therapy in lymphomas: A report from the Italian CART‐SIE study
Angelica Barone, A. Chiappella, B. Casadei, S. Bramanti +15 more
2024British Journal of Haematology13 citations Open access
Semantic Scholar
Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study
S. Bramanti, D. Mannina, A. Chiappella, B. Casadei +10 more
2024Bone Marrow Transplantation12 citations Open access
Semantic Scholar
CAR T expansion and systemic inflammation: diverging impacts on large B-cell lymphoma therapy in the multicenter CART SIE study
M. Magni, Sadhana Jonnalagadda, F. Bonifazi, Massimiliano Bonafé +22 more
2025Haematologica11 citations Open access
Semantic Scholar
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi
A. Arcari, Lucia Morello, D. Vallisa, L. Marcheselli +22 more
2021Leukemia and Lymphoma11 citations
Semantic Scholar
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
V. Tabanelli, F. Melle, G. Motta, S. Mazzara +17 more
2022Blood Advances10 citations Open access
Semantic Scholar
Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase IB/II study
T. Phillips, M. Brunvand, Andy I. Chen, J. Essell +7 more
2021American journal of hematology/oncology8 citations Open access
Semantic Scholar
A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma
E. Derenzini, S. Mazzara, F. Melle, G. Motta +21 more
2020Haematologica8 citations Open access
Semantic Scholar
Aggressive Non-Hodgkin lymphomas: risk factors and treatment of central nervous system recurrence
Elisa Santambrogio, M. Nicolosi, F. Vassallo, A. Castellino +3 more
2019Expert Review of Hematology8 citations
Semantic Scholar
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial.
Georg Lenz, M. Trněný, John M. Burke, Grzegorz S. Nowakowski +22 more
2026The Lancet7 citations Open access
Semantic Scholar
Biological features and outcome of diffuse large B‐cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective ‘Elderly Project’ by the Fondazione Italiana Linfomi
A. Arcari, V. Tabanelli, F. Merli, L. Marcheselli +21 more
2023British Journal of Haematology7 citations
Semantic Scholar
Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis
A. Dodero, G. Ceparano, B. Casadei, P. Angelillo +20 more
2025Blood Advances6 citations Open access
Semantic Scholar
Brexucabtagene autoleucel in‐vivo expansion and BTKi refractoriness have a negative influence on progression‐free survival in mantle cell lymphoma: Results from CART‐SIE study
F. Stella, A. Chiappella, M. Magni, F. Bonifazi +21 more
2024British Journal of Haematology6 citations Open access
Semantic Scholar
Frontmind: A Phase III, Multicenter, Randomized, Double-Blind Study of Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP Alone for Newly Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma
U. Vitolo, G. Nowakowski, J. Burke, C. Fox +6 more
2022Blood6 citations Open access
Semantic Scholar
ABCL-021: FRONT-MIND: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy and Safety of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP Alone for Newly-Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
U. Vitolo, G. Nowakowski, J. Burke, C. Fox +6 more
20216 citations
Semantic Scholar
Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: A Delphi consensus.
S. Luminari, A. Chiappella, A. Di Rocco, L. Arcaini +8 more
2025Cytotherapy5 citations Open access
Semantic Scholar
Real-Life CAR-T Cell Treatment in Large B-Cell Lymphomas Indicates That Axi-Cel and Tisa-Cel Have Similar Outcomes, but Long-Term Cytopenia Is an Emerging Problem
A. Chiappella, A. Guidetti, A. Dodero, S. Bramanti +18 more
2021Blood5 citations Open access
Semantic Scholar
THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI: A PROSPECTIVE COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) OF 1353 ELDERLY PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA
M. Spina, F. Merli, Benedetta Puccini, F. Cavallo +31 more
2019Hematological Oncology5 citations
Semantic Scholar
Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas
E. Fardella, G. Zanirato, M. Magni, N. Caldarelli +12 more
2024British Journal of Haematology4 citations Open access
Semantic Scholar
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma
C. De Philippis, Cristina Zucchinetti, D. Mannina, M. Krampera +9 more
2024Bone Marrow Transplantation4 citations Open access
Semantic Scholar
frontMIND: A phase III, randomized, double-blind study of tafasitamab + lenalidomide + R-CHOP versus R-CHOP alone for newly diagnosed high-intermediate and high-risk diffuse large B-cell lymphoma.
U. Vitolo, G. Nowakowski, J. Burke, C. Fox +6 more
2022Journal of Clinical Oncology4 citations
Semantic Scholar
Adding Romidepsin to CHOEP in First Line Treatment of Peripheral T-Cell Lymphomas Does Not Improve the Response Rate: Final Analysis of Phase II PTCL13 Study
A. Chiappella, C. Carniti, A. Re, C. Castellino +29 more
2021Blood4 citations Open access
Semantic Scholar
Tisagenlecleucel and Axicabtagene Ciloleucel Expansion Kinetics and CAR T Cell Attributes in the Infusion Products Are Early Predictors of Clinical Efficacy
C. Carniti, C. Monfrini, V. Aragona, M. Magni +9 more
2021Blood4 citations Open access
Semantic Scholar
Long-Term Results from a Phase 1b Study of Avadomide in Combination with Obinutuzumab in Patients with Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma
J. Michot, R. Bouabdallah, J. Doorduijn, C. Boccomini +14 more
20204 citations Open access
Semantic Scholar
The role of autologous haematopoietic stem-cell transplantation in mantle cell lymphoma.
A. Chiappella, M. Ladetto
2021The Lancet Haematology3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

U. Vitolo×16
Invite
U. Vitolo — researcher profile on SciRah
P. Zinzani×16
Invite
P. Zinzani — researcher profile on SciRah
A. Dodero×16
Invite
A. Dodero — researcher profile on SciRah
A. Di Rocco×15
Invite
A. Di Rocco — researcher profile on SciRah

×12

Invite

S. Bramanti — researcher profile on SciRah

Invite

M. Tisi — researcher profile on SciRah

Invite

S. Ljevar — researcher profile on SciRah

P. Corradini×11

Invite

P. Corradini — researcher profile on SciRah

Invite

C. Carniti — researcher profile on SciRah

M. Balzarotti×10

Invite

M. Balzarotti — researcher profile on SciRah

P. Corradini×10

Invite

P. Corradini — researcher profile on SciRah

Invite

V. Zilioli — researcher profile on SciRah